S. Rajamani

Validation of the cell cycle progression score to differentiate indolent from aggressive prostate cancer in men diagnosed through transurethral resection of the prostate biopsy

J. Cuzick, D. Berney, P. Scardino, 2021, Cancer reports.

Cell cycle progression score predicts metastatic progression of clear cell renal cell carcinoma after resection.

R. Askeland, S. Stone, James A. Brown, 2015, Cancer biomarkers : section A of Disease markers.

MP36-05 CELL CYCLE PROGRESSION SCORE PREDICTS METASTATIC PROGRESSION OF CLEAR CELL RENAL CELL CARCINOMA AFTER RESECTION

R. Askeland, S. Stone, James A. Brown, 2014 .

Analysis of the prognostic utility of the cell cycle progression (CCP) score generated from needle biopsy in men treated with definitive therapy

J. Bishoff, T. Schlomm, S. Freedland, 2019, Prostate Cancer and Prostatic Diseases.

Comparison of the Prognostic Utility of the Cell Cycle Progression Score for Predicting Clinical Outcomes in African American and Non-African American Men with Localized Prostate Cancer.

J. Reid, M. Brawer, S. Stone, 2019, European urology.

Identification of men with low-risk biopsy-confirmed prostate cancer as candidates for active surveillance.

J. Cuzick, P. Scardino, E. Crawford, 2018, Urologic oncology.

The clinical cell-cycle risk (CCR) score is associated with metastasis after radiation therapy and provides guidance on when to forgo combined androgen deprivation therapy with dose-escalated radiation.

J. Tward, C. Olsson, M. Brawer, 2021, International journal of radiation oncology, biology, physics.

Analytical validation of a 12-gene molecular test for the prediction of distant recurrence in breast cancer

J. Reid, R. Kronenwett, M. B. Warf, 2017, Future science OA.

Automating Ground Truth Annotations for Gland Segmentation Through Immunohistochemistry.

M. Bronner, B. Knudsen, Shireen Elhabian, 2023, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.